Ki-67 and Survivin as Predictive Factors for Rectal Cancer Treated with Preoperative Chemoradiotherapy.

Abstract:

AIM:To evaluate the usefulness of Ki-67 index and survivin as predictive prognostic factors for rectal cancer treated with preoperative chemoradiotherapy. PATIENTS AND METHODS:The Ki-67 index and survivin expression were examined in patients with stage II/III rectal cancer (n=46) by immunohistochemistry. Patients were divided into a high-group and a low-group for the Ki-67 index, and positive and negative groups for survivin expression. Overall and disease-free survival were compared between the groups, and the correlation between Ki-67 index and survivin expression was assessed. RESULTS:The 5-year disease-free survival rate of the group with high Ki-67 index was significantly lower than that of the group with low Ki-67 index (53% and 88%, p=0.03), as was the 5-year overall survival rate (68% and 100%, p=0.03). Findings for survivin were not significant. CONCLUSION:Ki-67 index and survivin may be useful biomarkers for rectal cancer with preoperative CRT.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Yoshikawa K,Shimada M,Higashijima J,Nakao T,Nishi M,Takasu C,Kashihara H,Eto S,Bando Y

doi

10.21873/anticanres.12409

subject

Has Abstract

pub_date

2018-03-01 00:00:00

pages

1735-1739

issue

3

eissn

0250-7005

issn

1791-7530

pii

38/3/1735

journal_volume

38

pub_type

杂志文章
  • Lack of association among polymorphic xenobiotic-metabolizing enzyme genotypes and the occurrence and progression of oral carcinoma in a Brazilian population.

    abstract:BACKGROUND:A case control association study was carried out to investigate polymorphisms in genes CYP1A1 (3801T > C), GSTM1, and GSTT1 (null genotypes) and oral squamous cell carcinoma (OSCC), including a correlation with some histopathological findings (tumor size, lymph node invasion and degree of tumor differentiati...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Losi-Guembarovski R,Cólus IM,De Menezes RP,Poliseli F,Chaves VN,Kuasne H,Leichsenring A,Guembarovski AL,Oliveira BW,Ramos G,Cavalcanti TC,Mizuno LT,Cavalli IJ,Ribeiro EM

    更新日期:2008-03-01 00:00:00

  • Cryotreatment against metastatic renal cell bone tumour reduced multiple lung metastases.

    abstract::Metastatic renal cell carcinoma (RCC) has a poor response to anticancer chemotherapy and radiotherapy. While immunotherapy and molecular targeted drugs have been used as first-line therapy for RCC metastasis, the response rate to these agents is low. We report the case of a patient with lung and bone metastases of RCC...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nishida H,Shirai T,Hayashi K,Takeuchi A,Tanzawa Y,Mizokami A,Namiki M,Tsuchiya H

    更新日期:2011-09-01 00:00:00

  • Differentiating benign and malignant pulmonary lesions with FDG-PET.

    abstract::The purpose of this retrospective study was to evaluate the efficacy of positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to differentiate benign from malignant pulmonary lesions. Fifty-five patients, suspected of having primary pulmonary neoplasm based on chest radiographic findings, underwent F...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yang SN,Liang JA,Lin FJ,Kwan AS,Kao CH,Shen YY

    更新日期:2001-11-01 00:00:00

  • Cell death-inducing activity of opiates in human oral tumor cell lines.

    abstract::In screening cytotoxic agents in morphine alkaloids [TE1-10], codeinone [TE8] was cytotoxic against two human oral tumor cells lines (HSC-2 and HSG). The cytotoxic activity of codeinone (CC50=1.0-1.2 microg/mL) against HSC-2 or HSG cells was higher than that of doxorubicin (CC50=1.9-2.0 microg/mL). Human oral gingival...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kawase M,Sakagami H,Furuya K,Kikuchi H,Nishikawa H,Motohashi N,Morimoto Y,Varga A,Molnár J

    更新日期:2002-01-01 00:00:00

  • Chemo-immunotherapy of ovarian cancer in a murine tumour model.

    abstract:BACKGROUND:As a majority of ovarian cancer patients will ultimately develop recurrent disease, there is an urgent need for alternative or additional approaches in the treatment of this cancer. MATERIALS AND METHODS:The antitumour effect of i.p. administered cisplatin, liposomal muramyltripeptide phosphatidylethanulami...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Klimp AH,De Vries EG,Scherphof GL,Daemen T

    更新日期:2000-07-01 00:00:00

  • Mode of action of anticancer peptides (ACPs) from amphibian origin.

    abstract::Although cancer belongs to one of the leading causes of death around the world, fortunately studies have shown that tumor cells have various targets that are susceptible to attack. Interestingly, tumor cells are comprised of cellular membranes, which are altered in chemical composition relative to non-neoplastic cells...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Oelkrug C,Hartke M,Schubert A

    更新日期:2015-02-01 00:00:00

  • Augmented pro-apoptotic effects of TRAIL and proteasome inhibitor in human promonocytic leukemic U937 cells.

    abstract::TRAIL, Tumor necrosis factor-related apoptosis-inducing ligand), a member of the TNF family, is known to be cytotoxic for a high proportion of tumor cell lines. However, successful application of TRAIL in tumor therapy may depend on finding other agents that can potentiate its antitumor effects. The present study show...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Młynarczuk I,Hoser G,Grzela T,Stokłosa T,Wójcik C,Malejczyk J,Jakóbisiak M

    更新日期:2001-03-01 00:00:00

  • Developing a decision-making model based on an interdisciplinary oncological care group for the management of colorectal cancer.

    abstract:AIM:To report our experience on implementation and preliminary results of a decision-making model based on the recommendations of an Interdisciplinary Oncological Care Group developed for the management of colorectal cancer. PATIENTS AND METHODS:The multidisciplinary team identified a reference guideline using apprais...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Genovesi D,Mazzilli L,Trignani M,DI Tommaso M,Nuzzo A,Biondi E,Tinari N,Martino MT,Innocenti P,DI Sebastiano P,Mazzola L,Lanci C,Neri M,Laterza F,Marino M,Ferrini G,Spadaccini A,Filippone A,DI Giandomenico E,Marulli

    更新日期:2014-05-01 00:00:00

  • Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer.

    abstract:BACKGROUND:Genetic alterations occurring in lung cancer are the basis for defining molecular subtypes and essential for targeted therapies. Exhaled breath condensate (EBC) is a form of non-invasive sample that, amongst components, contains DNA from pulmonary tissue. Next-generation sequencing (NGS) was herein used to a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12897

    authors: Youssef O,Knuuttila A,Piirilä P,Böhling T,Sarhadi V,Knuutila S

    更新日期:2018-10-01 00:00:00

  • Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.

    abstract::We have previously shown that transfection of NIH 3T3 cells with the T24 H-ras oncogene converts the cells to a tumorigenic and metastatic phenotype, in proportion to levels of ras expression. We hypothesize that ras-induced increases in malignancy occur via altered expression of various genes. We have identified OPN ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chambers AF,Behrend EI,Wilson SM,Denhardt DT

    更新日期:1992-01-01 00:00:00

  • Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature.

    abstract::The use of salvage chemotherapy in advanced non small cell lung cancer (NSCLC) is controversial. However, many patients need to be treated in order to achieve relief of their symptoms. Docetaxel (taxotere) is one of the most active drugs for the treatment of advanced NSCLC and several studies have also shown its effec...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,多中心研究,评审

    doi:

    authors: Gridelli C,Frontini L,Barletta E,Rossi A,Barzelloni ML,Scognamiglio F,Guida C,Gatani T,Fiore F,De Bellis M,Marfella A,Manzione L

    更新日期:2000-03-01 00:00:00

  • High-dose chemotherapy in small-cell lung cancer.

    abstract::Small cell lung cancer (SCLC) is highly sensitive both to radiotherapy and chemotherapy. Given its high chemo sensitivity, even two decades ago, SCLC was one of the first malignancies deemed suitable for maximising the dose and dose intensity with the support of autologous bone marrow (ABMT). On the whole, results wer...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Pasini F,Durante E,De Manzoni D,Rosti G,Pelosi G

    更新日期:2002-11-01 00:00:00

  • Raloxifene attenuation of methotrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-FU/methotrexate.

    abstract:BACKGROUND:Increasing evidence suggests that adjuvant systemic chemotherapy is necessary for the survival of breast cancer patients. Antitumor agents are more effective when used in combination with drugs exhibiting different mechanisms of action than when used alone. Previous studies from this laboratory have shown th...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Das JR,Fryar EB,Epie NN,Southerland WM,Bowen D

    更新日期:2006-05-01 00:00:00

  • A 12-year Recurrence-free Survival After Multidisciplinary Treatment for a Patient With Combined Hepatocellular-Cholangiocarcinoma.

    abstract::We report a 64-year-old woman with a 9-cm liver tumor in the left lateral section. The patient had neither hepatitis B or C virus infection, nor cirrhosis. Carbohydrate antigen 19-9 (CA 19-9) level was 1,889 U/ml. We also suspected bulky hilar lymph node metastasis, and a left lateral sectionectomy without lymph node ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13327

    authors: Miyata T,Beppu T,Imamura YU,Hayashi H,Imai K,Chikamoto A,Yamashita YI,Fukubayashi K,Ishiko T,Baba H

    更新日期:2019-04-01 00:00:00

  • A phase-II study of liposomal doxorubicin and docetaxel in patients with advanced pancreatic cancer.

    abstract:BACKGROUND:Both liposomal doxorubicin (LD) and docetaxel (D) have a broad range of activity against solid tumors, including advanced pancreatic cancer (APC), as single agents, while their combination has produced encouraging response rates in the treatment of several malignancies. We have conducted a Phase-II study in ...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Syrigos KN,Michalaki B,Alevyzaki F,Machairas A,Mandrekas D,Kindilidis K,Karatzas G

    更新日期:2002-11-01 00:00:00

  • Cytogenetic investigations in four canine lymphomas.

    abstract::Four cases of canine lymphoma are presented, including histological examination and cytogenetic investigation. The first case showed a derivative chromosome 13, the second case showed a clonal trisomy 8 and the third case showed a complex karyotype with a clonal trisomy 13 and additional clonal trisomies of the chromo...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Winkler S,Murua Escobar H,Reimann-Berg N,Bullerdiek J,Nolte I

    更新日期:2005-11-01 00:00:00

  • A high-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors.

    abstract::A high-throughput 32D(L858R/T790M) cell-based assay to identify inhibitors of the L858R/T790M mutant epidermal growth factor receptor (EGFR) pathway was established. After screening, ten hits from among 60,000 compounds in our in-house compound library were initially identified. In the secondary assays, one hit, 1-[2-...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Lin WH,Song JS,Lien TW,Chang CY,Wu SH,Huang YW,Chang TY,Fang MY,Yen KJ,Chen CH,Chu CY,Hsieh HP,Chen YR,Chao YS,Hsu JT

    更新日期:2012-01-01 00:00:00

  • Comparison of the Serum Tumor Markers S100 and Melanoma-inhibitory Activity (MIA) in the Monitoring of Patients with Metastatic Melanoma Receiving Vaccination Immunotherapy with Dendritic Cells.

    abstract:BACKGROUND:In patients with melanoma, early dissemination via lymphatic and hematogenous routes is frequently seen. Thus, besides clinical follow-up examination and imaging, reliable melanoma-specific serological tumor markers are needed. PATIENTS AND METHODS:We retrospectively compared two serum markers for melanoma,...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11918

    authors: Uslu U,Schliep S,Schliep K,Erdmann M,Koch HU,Parsch H,Rosenheinrich S,Anzengruber D,Bosserhoff AK,Schuler G,Schuler-Thurner B

    更新日期:2017-09-01 00:00:00

  • Induction of apoptosis by epigallocatechin gallate and autophagy inhibitors in a mouse macrophage-like cell line.

    abstract::We have previously reported that lignin carbohydrate complex and E. coli lipopolysaccharide (LPS), but not their precursors or (-)-epigallocatechin-3-gallate (EGCG), enhanced the nitric oxide (NO), citrulline and asparagines production by the mouse-macrophage-like cell line Raw264.7. Here the EGCG inhibition of NO pro...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Hashimoto K,Sakagami H

    更新日期:2008-05-01 00:00:00

  • Neoadjuvant chemotherapy in Barrett's carcinoma - prognosis and response prediction.

    abstract::In spite of endoscopic surveillance programs, 90% of patients initially presenting with Barrett's carcinoma have locally advanced disease. In these patients, preoperative chemotherapy increases the chance of a curative resection in responding patients. Unfortunately, response occurs in only 50% of patients after chemo...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Schauer M,Knoefel WT

    更新日期:2010-04-01 00:00:00

  • Current Status and Problems of T790M Detection, a Molecular Biomarker of Acquired Resistance to EGFR Tyrosine Kinase Inhibitors, with Liquid Biopsy and Re-biopsy.

    abstract:BACKGROUND/AIM:The purpose of this study was to consider appropriate application of liquid and re-biopsy through analysis of current status in practice. PATIENTS AND METHODS:We performed a retrospective analysis of 22 patients with epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer wh...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12628

    authors: Komiya K,Nakashima C,Nakamura T,Hirakawa H,Abe T,Ogusu S,Takahashi K,Takeda Y,Egashira Y,Kimura S,Sueoka-Aragane N

    更新日期:2018-06-01 00:00:00

  • Symptomatic intraosseous lipoma in the calcaneus.

    abstract:BACKGROUND:Intraosseous lipoma remains a poorly-characterized tumor. In paticular, the natural course of intracalcaneus lipoma after conservative treatment and the appropriate surgical modalities are still quite controversial. PATIENTS AND METHODS:We reviewed six symptomatic patients who underwent curettage of intraca...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Muramatsu K,Tominaga Y,Hashimoto T,Taguchi T

    更新日期:2014-02-01 00:00:00

  • Dosimetry of a 238Pu-based alpha-particle irradiator and its biological application in a study of the bystander effect.

    abstract::A better understanding of the non-targeted (bystander) effects of radiation may have important implications with regards to radiation risk assessment, radiation protection, and targeted cancer therapy. In the present study, the direct and bystander effects of α-particle irradiation in immortalized human fibroblasts (F...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Dahle J,Kalanxhi E,Tisnek N

    更新日期:2011-06-01 00:00:00

  • Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.

    abstract:BACKGROUND:Cyclin D1 is a key protein involved in cell cycle regulation. A common A870G single nucleotide polymorphism in exon 4 of the cyclin D1 gene (CCND1) has an effect on the transcription of two different cyclin D1 mRNAs. Association of the genetic polymorphism of A870G of CCND1 with several cancer risks has been...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Koike H,Suzuki K,Satoh T,Ohtake N,Takei T,Nakata S,Yamanaka H

    更新日期:2003-11-01 00:00:00

  • SN-38 Acts as a Radiosensitizer for Colorectal Cancer by Inhibiting the Radiation-induced Up-regulation of HIF-1α.

    abstract:BACKGROUND/AIM:Hypoxia offers resistance to therapy in human solid tumors. The aim of the study was to investigate whether SN-38, the active metabolite of irinotecan, acts as a radiosensitizer through inhibition of hypoxia-inducible factor (HIF)-1α in the human colorectal cancer (CRC) cells. MATERIALS AND METHODS:HT29...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12598

    authors: Okuno T,Kawai K,Hata K,Murono K,Emoto S,Kaneko M,Sasaki K,Nishikawa T,Tanaka T,Nozawa H

    更新日期:2018-06-01 00:00:00

  • Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1/Pgp, p53, and metallothionein (MT) proteins.

    abstract:BACKGROUND:Although in vitro and clinical studies indicate that overexpression of P-glycoprotein (Pgp), p53, or metallothionein (MT) is involved in modulating drug resistance/sensitivity of cancer cells, the clinical relevance of the overexpression remains to be elucidated. MATERIALS AND METHODS:In this paper the expr...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Eid H,Géczi L,Mágori A,Bodrogi I,Institoris E,Bak M

    更新日期:1998-07-01 00:00:00

  • No evidence of stimulation of human tumor cell proliferation by a standardized aqueous mistletoe extract in vitro.

    abstract::The in vitro antiproliferative or stimulatory activity of an aqueous mistletoe extract (AME) with a defined content of bioactive mistletoe lectin (ML) was investigated in 6 human tumor cell lines, including two melanomas and leiomyosarcomas, each of which had previously been reported to show evidence of growth stimula...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Burger AM,Mengs U,Kelter G,Schüler JB,Fiebig HH

    更新日期:2003-09-01 00:00:00

  • Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).

    abstract:BACKGROUND:Doxorubicin remains one of the few drugs with consistent single agent activity in advanced Soft Tissue Sarcomas (STS), with a demonstrated dose-response relationship. Liposomal-encapsulated Doxorubicin (LED) has been shown to be at least as active as free doxorubicin in experimental models, and phase I and I...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Toma S,Tucci A,Villani G,Carteni G,Spadini N,Palumbo R

    更新日期:2000-01-01 00:00:00

  • Crizotinib Fails to Enhance the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Xenografts.

    abstract:AIM:Mesenchymal-epithelial transition factor (MET), a receptor tyrosine kinase, is expressed in head and neck squamous cell carcinomas (HNSCC) and is involved in tumor progression and associated with poor prognosis. MET can be inhibited by crizotinib, a potent ATP-competitive kinase inhibitor. We examined the effects o...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Baschnagel AM,Galoforo S,Thibodeau BJ,Ahmed S,Nirmal S,Akervall J,Wilson GD

    更新日期:2015-11-01 00:00:00

  • Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.

    abstract::Glioblastoma multiforme (GBM) represents the most malignant primary brain tumor in adults with generally dismal prognosis, early clinical deterioration and high mortality. GBM is extremely invasive, characterized by intense and aberrant vascularization and high resistance to multimodal treatment. Standard therapy (sur...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:10.21873/anticanres.11285

    authors: Polivka J Jr,Polivka J,Holubec L,Kubikova T,Priban V,Hes O,Pivovarcikova K,Treskova I

    更新日期:2017-01-01 00:00:00